FAP and pancreatic neoplasm: In pancreatic cancer, multiple FAP‐targeted probes, such as TEFAPI‐06 and 07, as well as 177Lu–FAPI‐46, have demonstrated improved tumor retention and significant tumor growth inhibition in mouse models.